Established in 1999, Medtrade (CELOX PPH Ltd) is a dynamic UK-based biotechnology company that has been driving innovation and delivering industry-leading solutions on a global scale. With a presence in Crewe, UK, and New York, US, we are at the forefront of addressing crucial healthcare needs, particularly in wound care, trauma and haemostasis.

Our accomplished team is passionately committed to developing cutting-edge solutions that tackle pressing global healthcare challenges, including biofilms, wound treatment, infection prevention, and bleeding control. As an ISO 13485 certified company, we boast a proven track record of efficiently supporting brand owners by providing market-leading solutions that adhere to the highest quality standards.

With CELOX™ PPH as a shining example of our dedication, Medtrade is reshaping the landscape of maternal health and postpartum care. Through unwavering innovation and a commitment to excellence, we continue to make significant strides in ensuring safer, more efficient healthcare practices and better outcomes for patients worldwide.